PeterMD vs Zealthy: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

52 providers verified independently·Independent research·How we rank →

PeterMD beats Zealthy overall, scoring 7.3/10 vs 7.2/10. PeterMD is more affordable at $165/mo vs $286/mo. Choose PeterMD for budget-conscious users looking for the lowest monthly glp-1 . Choose Zealthy for insured users who want dedicated coordinators handling prior.

A side-by-side look at PeterMD and Zealthy to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Higher Rated

PeterMD

#32 of 52

7.3/10

One of the most affordable compounded GLP-1 options on the market, ideal for budget-conscious patients.

Visit PeterMD

Zealthy

#41 of 52

7.2/10

Flexible GLP-1 provider allowing patients to switch between compounded and brand-name medications as needed.

Visit Zealthy

Feature	PeterMD	Zealthy
Our Score	7.3/10	7.2/10
Starting Price	$165/mo	$286/mo
Medication Type	Compounded	Both
Insurance Accepted	No	No
Best For	Budget-conscious users looking for the lowest monthly GLP-1 cost	Insured users who want dedicated coordinators handling prior authorizations for brand-name GLP-1s (potentially $25/mo)
Ranking	#32	#41
Get started	Visit PeterMD	Visit Zealthy

Pros & Cons Compared

PeterMD

Pros

+Flat $165/mo at all dose levels, price doesn't increase as you titrate up to maintenance doses
+100,000+ patient base with 4.9/5 Trustpilot rating from 14,000+ reviews, strong social proof
+Semaglutide + B12 formulation helps reduce nausea, the most common GLP-1 side effect
+Video consultations with physicians included, real face-to-face medical oversight

Cons

−Available in 42 states, not all 50 (8 states are excluded). Check your state during signup before planning around PeterMD.
−Not BBB accredited, and some documented complaints cite delayed medication fulfillment. Order refills ahead of your last dose rather than at the last minute.
−PeterMD began as a testosterone replacement therapy platform; GLP-1 is an expansion, not the original core. The included video consultations give you a direct read on the clinical team.

Zealthy

Pros

+Dedicated insurance coordinators handle prior authorizations, potentially bringing brand-name GLP-1 costs to $25/mo
+Multi-month supply options (3, 6, or 12 months), unique convenience most monthly-shipping competitors can't match
+Both compounded and brand-name (Wegovy, Zepbound) available with clinician-guided selection
+LegitScript certified with 4.5-star Review.io rating

Cons

−The $135 membership stacks on medication cost, so cash-pay semaglutide totals ~$286/mo, above average. The math works when you use the insurance coordination; cash payers should compare flat-rate platforms first.
−Young company (founded 2023) with a relatively small review base and less track record than established platforms. Confirm the coordination promise against your own insurance plan before enrolling.
−Prescription products are non-refundable once ordered, for any reason. Double-check dose and supply length before checkout.

Our Verdict

PeterMD edges out Zealthy with a score of 7.3/10 vs 7.2/10. If budget is your priority, PeterMD starts at $165/mo compared to Zealthy's $286/mo. Zealthy offers both brand-name and compounded medications, giving you more flexibility. Choose PeterMD if you want: budget-conscious users looking for the lowest monthly glp-1 cost. Choose Zealthy if you want: insured users who want dedicated coordinators handling prior authorizations for brand-name glp-1s (potentially $25/mo).

Still undecided? Editor's Featured Pick

Yucca Health

$146/mo · 7.7/10 · Compounded

If neither PeterMD nor Zealthy feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.

Visit Yucca Health→Read our full Yucca Health review